- Investing Ideas
- Pakistani Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Pakistani Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
2
0 new
High return on equity, past performance and sound balance sheet.
2 companies
GlaxoSmithKline Pakistan
Market Cap: PK₨110.4b
A biopharma company, engages in the discovery, development, and delivery of medicines and vaccines in Pakistan.
GLAXO
PK₨346.68
7D
-0.9%
1Y
-11.3%
Highnoon Laboratories
Market Cap: PK₨51.3b
Together with its subsidiary, engages in the development, production, marketing, and distribution of pharmaceutical and allied consumer products in Pakistan, Afghanistan, the United Arab Emirates, Sri Lanka, France, Sudan, Cambodia, Kenya, Iraq, Dubai, Tanzania, and internationally.
HINOON
PK₨968.98
7D
-2.5%
1Y
5.4%